12/11
08:21 am
cmrx
Chimerix, Inc. (NASDAQ: CMRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
High
Report
Chimerix, Inc. (NASDAQ: CMRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
12/10
06:20 pm
cmrx
Chimerix, Inc. (NASDAQ: CMRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.
Low
Report
Chimerix, Inc. (NASDAQ: CMRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.
12/10
09:46 am
cmrx
Why Is Cancer-Focused Chimerix Stock Trading Higher On Tuesday? [Yahoo! Finance]
Medium
Report
Why Is Cancer-Focused Chimerix Stock Trading Higher On Tuesday? [Yahoo! Finance]
12/9
04:19 pm
cmrx
Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End [Yahoo! Finance]
High
Report
Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End [Yahoo! Finance]
12/9
04:01 pm
cmrx
Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End
High
Report
Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End
12/6
04:01 pm
cmrx
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/18
11:34 am
cmrx
Chimerix, Inc. (NASDAQ: CMRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.
Low
Report
Chimerix, Inc. (NASDAQ: CMRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.
11/11
11:18 am
cmrx
Chimerix, Inc. (NASDAQ: CMRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
Low
Report
Chimerix, Inc. (NASDAQ: CMRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
11/11
07:00 am
cmrx
Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting
Medium
Report
Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting
11/9
08:10 am
cmrx
Chimerix Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
Medium
Report
Chimerix Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
11/8
02:21 am
cmrx
Chimerix Inc (CMRX) Q3 2024 Earnings Call Highlights: Strategic Advancements Amid Financial ... [Yahoo! Finance]
Medium
Report
Chimerix Inc (CMRX) Q3 2024 Earnings Call Highlights: Strategic Advancements Amid Financial ... [Yahoo! Finance]
11/7
07:00 am
cmrx
Chimerix Reports Third Quarter 2024 Financial Results and Provides Operational Update
Medium
Report
Chimerix Reports Third Quarter 2024 Financial Results and Provides Operational Update
11/6
07:57 am
cmrx
Chimerix Inc (CMRX) Q3 2024: Everything You Need to Know Ahead of Earnings [Yahoo! Finance]
Medium
Report
Chimerix Inc (CMRX) Q3 2024: Everything You Need to Know Ahead of Earnings [Yahoo! Finance]
11/1
07:00 am
cmrx
Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024
Low
Report
Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024
10/18
04:31 pm
cmrx
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
9/22
09:48 am
cmrx
Here's Why We're Watching Chimerix's (NASDAQ:CMRX) Cash Burn Situation [Yahoo! Finance]
Medium
Report
Here's Why We're Watching Chimerix's (NASDAQ:CMRX) Cash Burn Situation [Yahoo! Finance]